APO Research
Talk to an analyst

APO RESEARCH · REPORT

Temperature Controlled Package for Pharmaceutical

In the pharmaceutical industry, the quality of pharmaceutical products has a direct effect on patient safety and the efficacy of patient therapies. Temperature Controlled Package for Pharmaceutical is designed for the safe and efficient transport of pharmaceuticals, biologics, vaccines and other temperature-sensitive products. Temperature-controlled packaging solutions for pharmaceuticals are an important tool in reducing the risk and maintaining quality of product throughout the supply chain process by stabilizing internal temperature. This system helps to safeguard shipments across every aspect of the medical supply chain.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

In the pharmaceutical industry, the quality of pharmaceutical products has a direct effect on patient safety and the efficacy of patient therapies. Temperature Controlled Package for Pharmaceutical is designed for the safe and efficient transport of pharmaceuticals, biologics, vaccines and other temperature-sensitive products. Temperature-controlled packaging solutions for pharmaceuticals are an important tool in reducing the risk and maintaining quality of product throughout the supply chain process by stabilizing internal temperature. This system helps to safeguard shipments across every aspect of the medical supply chain.

Selected research

Market Outlook & Growth Opportunities

Global Temperature Controlled Package for Pharmaceutical Market Outlook and Growth Opportunities 2026

28 December 2025217 pages

Choose your research edition.

Industry ResearchTemperature Controlled Package for Pharmaceutical Industry Research Report 2026150 pages · $2,950 USDIndustry Growth & TrendsGlobal Temperature Controlled Package for Pharmaceutical Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Temperature Controlled Package for Pharmaceutical Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Temperature Controlled Package for Pharmaceutical Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Temperature Controlled Package for Pharmaceutical Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

In the pharmaceutical industry, the quality of pharmaceutical products has a direct effect on patient safety and the efficacy of patient therapies. Temperature Controlled Package for Pharmaceutical is designed for the safe and efficient transport of pharmaceuticals, biologics, vaccines and other temperature-sensitive products. Temperature-controlled packaging solutions for pharmaceuticals are an important tool in reducing the risk and maintaining quality of product throughout the supply chain process by stabilizing internal temperature. This system helps to safeguard shipments across every aspect of the medical supply chain.

The classification of temperature controlled package for pharmaceutical includes single use temperature controlled package and reusable temperature controlled package.Temperature Controlled Package for Pharmaceutical is widely used for temperature-sensitive pharmaceuticals, vaccines and other. The most proportion of temperature controlled package for pharmaceutical is temperature-sensitive pharmaceuticals.

North America is the largest consumption place, with a consumption market share nearly 34.02% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 29.17%.

Read the full market overview

Sonoco Products Company, Envirotainer, Pelican Biothermal, Cryopak, DS Smith Pharma, Cold Chain Technologies, Intelsius, CSafe, etc. are the leaders of the industry. The top6 accounts for about 15% of the market share.

This report provides an overview of the global Temperature Controlled Package for Pharmaceutical market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Temperature Controlled Package for Pharmaceutical and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Temperature Controlled Package for Pharmaceutical sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Temperature Controlled Package for Pharmaceutical market size, projected growth trends, production technologies, key applications, and end-use industries.

Temperature Controlled Package for Pharmaceutical Segment by Company

Sonoco Products Company

Envirotainer

Pelican Biothermal

Cryopak

DS Smith Pharma

Cold Chain Technologies

Intelsius

CSafe

Softbox Systems

World Courier

Skycell

Va-Q-tec AG

Sofrigam SA Ltd.

American Aerogel Corporation

EcoCool GmbH

Aeris Group

Dokasch

HAZGO

Beijing Roloo Technology

Insulated Products Corporation

Inmark Packaging

Guangzhou CCTS

Exeltainer SL

Cool Pac

Cryo Store

Temperature Controlled Package for Pharmaceutical Segment by Type

Single Use

Reusable

Temperature Controlled Package for Pharmaceutical Segment by Application

Temperature-Sensitive Pharmaceuticals

Vaccines

Others

Temperature Controlled Package for Pharmaceutical Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Temperature Controlled Package for Pharmaceutical status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Temperature Controlled Package for Pharmaceutical market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Temperature Controlled Package for Pharmaceutical significant trends, drivers, influence factors in global and regions.

6. To analyze Temperature Controlled Package for Pharmaceutical competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Temperature Controlled Package for Pharmaceutical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Temperature Controlled Package for Pharmaceutical and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Temperature Controlled Package for Pharmaceutical.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Temperature Controlled Package for Pharmaceutical market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Temperature Controlled Package for Pharmaceutical industry.

Chapter 3: Detailed analysis of Temperature Controlled Package for Pharmaceutical manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Temperature Controlled Package for Pharmaceutical in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Temperature Controlled Package for Pharmaceutical in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Temperature Controlled Package for Pharmaceutical Industry Trends Table 2. Temperature Controlled Package for Pharmaceutical Industry Drivers Table 3. Temperature Controlled Package for Pharmaceutical Industry Opportunities and Challenges Table 4. Temperature Controlled Package for Pharmaceutical Industry Restraints Table 5. Global Temperature Controlled Package for Pharmaceutical Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Temperature Controlled Package for Pharmaceutical Revenue Share by Company (2021-2026) Table 7. Global Temperature Controlled Package for Pharmaceutical Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Temperature Controlled Package for Pharmaceutical Sales Volume Share by Company (2021-2026) Table 9. Global Temperature Controlled Package for Pharmaceutical Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Temperature Controlled Package for Pharmaceutical Company Ranking, (2024-2026) & (USD Million) Table 11. Global Temperature Controlled Package for Pharmaceutical Key Company Manufacturing Base & Headquarters Table 12. Global Temperature Controlled Package for Pharmaceutical Company, Product Type & Application Table 13. Global Temperature Controlled Package for Pharmaceutical Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Temperature Controlled Package for Pharmaceutical by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Single Use Table 18. Significant Companies of Reusable Table 19. Global Temperature Controlled Package for Pharmaceutical Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Temperature Controlled Package for Pharmaceutical Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Temperature Controlled Package for Pharmaceutical Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Temperature Controlled Package for Pharmaceutical Sales Volume Share by Type (2021-2026) Table 23. Global Temperature Controlled Package for Pharmaceutical Sales Volume Share by Type (2027-2032) Table 24. Global Temperature Controlled Package for Pharmaceutical Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Temperature Controlled Package for Pharmaceutical Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Temperature Controlled Package for Pharmaceutical Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Temperature Controlled Package for Pharmaceutical Sales Value Share by Type (2021-2026) Table 28. Global Temperature Controlled Package for Pharmaceutical Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Temperature-Sensitive Pharmaceuticals Table 30. Significant Companies of Vaccines Table 31. Significant Companies of Others Table 32. Global Temperature Controlled Package for Pharmaceutical Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Temperature Controlled Package for Pharmaceutical Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Temperature Controlled Package for Pharmaceutical Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Temperature Controlled Package for Pharmaceutical Sales Volume Share by Application (2021-2026) Table 36. Global Temperature Controlled Package for Pharmaceutical Sales Volume Share by Application (2027-2032) Table 37. Global Temperature Controlled Package for Pharmaceutical Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Temperature Controlled Package for Pharmaceutical Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Temperature Controlled Package for Pharmaceutical Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Temperature Controlled Package for Pharmaceutical Sales Value Share by Application (2021-2026) Table 41. Global Temperature Controlled Package for Pharmaceutical Sales Value Share by Application (2027-2032) Table 42. Global Temperature Controlled Package for Pharmaceutical Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Temperature Controlled Package for Pharmaceutical Sales by Region (2021-2026) & (K Units) Table 44. Global Temperature Controlled Package for Pharmaceutical Sales Market Share by Region (2021-2026) Table 45. Global Temperature Controlled Package for Pharmaceutical Sales by Region (2027-2032) & (K Units) Table 46. Global Temperature Controlled Package for Pharmaceutical Sales Market Share by Region (2027-2032) Table 47. Global Temperature Controlled Package for Pharmaceutical Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Temperature Controlled Package for Pharmaceutical Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Temperature Controlled Package for Pharmaceutical Sales Value Share by Region (2021-2026) Table 50. Global Temperature Controlled Package for Pharmaceutical Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Temperature Controlled Package for Pharmaceutical Sales Value Share by Region (2027-2032) Table 52. Global Temperature Controlled Package for Pharmaceutical Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Temperature Controlled Package for Pharmaceutical Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Temperature Controlled Package for Pharmaceutical Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Temperature Controlled Package for Pharmaceutical Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Temperature Controlled Package for Pharmaceutical Sales by Country (2021-2026) & (K Units) Table 57. Global Temperature Controlled Package for Pharmaceutical Sales Market Share by Country (2021-2026) Table 58. Global Temperature Controlled Package for Pharmaceutical Sales by Country (2027-2032) & (K Units) Table 59. Global Temperature Controlled Package for Pharmaceutical Sales Market Share by Country (2027-2032) Table 60. Global Temperature Controlled Package for Pharmaceutical Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Temperature Controlled Package for Pharmaceutical Sales Value Market Share by Country (2021-2026) Table 62. Global Temperature Controlled Package for Pharmaceutical Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Temperature Controlled Package for Pharmaceutical Sales Value Market Share by Country (2027-2032) Table 64. Sonoco Products Company Company Information Table 65. Sonoco Products Company Business Overview Table 66. Sonoco Products Company Temperature Controlled Package for Pharmaceutical Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Sonoco Products Company Temperature Controlled Package for Pharmaceutical Product Portfolio Table 68. Sonoco Products Company Recent Development Table 69. Envirotainer Company Information Table 70. Envirotainer Business Overview Table 71. Envirotainer Temperature Controlled Package for Pharmaceutical Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Envirotainer Temperature Controlled Package for Pharmaceutical Product Portfolio Table 73. Envirotainer Recent Development Table 74. Pelican Biothermal Company Information Table 75. Pelican Biothermal Business Overview Table 76. Pelican Biothermal Temperature Controlled Package for Pharmaceutical Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Pelican Biothermal Temperature Controlled Package for Pharmaceutical Product Portfolio Table 78. Pelican Biothermal Recent Development Table 79. Cryopak Company Information Table 80. Cryopak Business Overview Table 81. Cryopak Temperature Controlled Package for Pharmaceutical Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Cryopak Temperature Controlled Package for Pharmaceutical Product Portfolio Table 83. Cryopak Recent Development Table 84. DS Smith Pharma Company Information Table 85. DS Smith Pharma Business Overview Table 86. DS Smith Pharma Temperature Controlled Package for Pharmaceutical Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. DS Smith Pharma Temperature Controlled Package for Pharmaceutical Product Portfolio Table 88. DS Smith Pharma Recent Development Table 89. Cold Chain Technologies Company Information Table 90. Cold Chain Technologies Business Overview Table 91. Cold Chain Technologies Temperature Controlled Package for Pharmaceutical Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Cold Chain Technologies Temperature Controlled Package for Pharmaceutical Product Portfolio Table 93. Cold Chain Technologies Recent Development Table 94. Intelsius Company Information Table 95. Intelsius Business Overview Table 96. Intelsius Temperature Controlled Package for Pharmaceutical Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Intelsius Temperature Controlled Package for Pharmaceutical Product Portfolio Table 98. Intelsius Recent Development Table 99. CSafe Company Information Table 100. CSafe Business Overview Table 101. CSafe Temperature Controlled Package for Pharmaceutical Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. CSafe Temperature Controlled Package for Pharmaceutical Product Portfolio Table 103. CSafe Recent Development Table 104. Softbox Systems Company Information Table 105. Softbox Systems Business Overview Table 106. Softbox Systems Temperature Controlled Package for Pharmaceutical Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Softbox Systems Temperature Controlled Package for Pharmaceutical Product Portfolio Table 108. Softbox Systems Recent Development Table 109. World Courier Company Information Table 110. World Courier Business Overview Table 111. World Courier Temperature Controlled Package for Pharmaceutical Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. World Courier Temperature Controlled Package for Pharmaceutical Product Portfolio Table 113. World Courier Recent Development Table 114. Skycell Company Information Table 115. Skycell Business Overview Table 116. Skycell Temperature Controlled Package for Pharmaceutical Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Skycell Temperature Controlled Package for Pharmaceutical Product Portfolio Table 118. Skycell Recent Development Table 119. Va-Q-tec AG Company Information Table 120. Va-Q-tec AG Business Overview Table 121. Va-Q-tec AG Temperature Controlled Package for Pharmaceutical Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Va-Q-tec AG Temperature Controlled Package for Pharmaceutical Product Portfolio Table 123. Va-Q-tec AG Recent Development Table 124. Sofrigam SA Ltd. Company Information Table 125. Sofrigam SA Ltd. Business Overview Table 126. Sofrigam SA Ltd. Temperature Controlled Package for Pharmaceutical Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Sofrigam SA Ltd. Temperature Controlled Package for Pharmaceutical Product Portfolio Table 128. Sofrigam SA Ltd. Recent Development Table 129. American Aerogel Corporation Company Information Table 130. American Aerogel Corporation Business Overview Table 131. American Aerogel Corporation Temperature Controlled Package for Pharmaceutical Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. American Aerogel Corporation Temperature Controlled Package for Pharmaceutical Product Portfolio Table 133. American Aerogel Corporation Recent Development Table 134. EcoCool GmbH Company Information Table 135. EcoCool GmbH Business Overview Table 136. EcoCool GmbH Temperature Controlled Package for Pharmaceutical Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. EcoCool GmbH Temperature Controlled Package for Pharmaceutical Product Portfolio Table 138. EcoCool GmbH Recent Development Table 139. Aeris Group Company Information Table 140. Aeris Group Business Overview Table 141. Aeris Group Temperature Controlled Package for Pharmaceutical Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Aeris Group Temperature Controlled Package for Pharmaceutical Product Portfolio Table 143. Aeris Group Recent Development Table 144. Dokasch Company Information Table 145. Dokasch Business Overview Table 146. Dokasch Temperature Controlled Package for Pharmaceutical Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Dokasch Temperature Controlled Package for Pharmaceutical Product Portfolio Table 148. Dokasch Recent Development Table 149. HAZGO Company Information Table 150. HAZGO Business Overview Table 151. HAZGO Temperature Controlled Package for Pharmaceutical Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 152. HAZGO Temperature Controlled Package for Pharmaceutical Product Portfolio Table 153. HAZGO Recent Development Table 154. Beijing Roloo Technology Company Information Table 155. Beijing Roloo Technology Business Overview Table 156. Beijing Roloo Technology Temperature Controlled Package for Pharmaceutical Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 157. Beijing Roloo Technology Temperature Controlled Package for Pharmaceutical Product Portfolio Table 158. Beijing Roloo Technology Recent Development Table 159. Insulated Products Corporation Company Information Table 160. Insulated Products Corporation Business Overview Table 161. Insulated Products Corporation Temperature Controlled Package for Pharmaceutical Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 162. Insulated Products Corporation Temperature Controlled Package for Pharmaceutical Product Portfolio Table 163. Insulated Products Corporation Recent Development Table 164. Inmark Packaging Company Information Table 165. Inmark Packaging Business Overview Table 166. Inmark Packaging Temperature Controlled Package for Pharmaceutical Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 167. Inmark Packaging Temperature Controlled Package for Pharmaceutical Product Portfolio Table 168. Inmark Packaging Recent Development Table 169. Guangzhou CCTS Company Information Table 170. Guangzhou CCTS Business Overview Table 171. Guangzhou CCTS Temperature Controlled Package for Pharmaceutical Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 172. Guangzhou CCTS Temperature Controlled Package for Pharmaceutical Product Portfolio Table 173. Guangzhou CCTS Recent Development Table 174. Exeltainer SL Company Information Table 175. Exeltainer SL Business Overview Table 176. Exeltainer SL Temperature Controlled Package for Pharmaceutical Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 177. Exeltainer SL Temperature Controlled Package for Pharmaceutical Product Portfolio Table 178. Exeltainer SL Recent Development Table 179. Cool Pac Company Information Table 180. Cool Pac Business Overview Table 181. Cool Pac Temperature Controlled Package for Pharmaceutical Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 182. Cool Pac Temperature Controlled Package for Pharmaceutical Product Portfolio Table 183. Cool Pac Recent Development Table 184. Cryo Store Company Information Table 185. Cryo Store Business Overview Table 186. Cryo Store Temperature Controlled Package for Pharmaceutical Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 187. Cryo Store Temperature Controlled Package for Pharmaceutical Product Portfolio Table 188. Cryo Store Recent Development Table 189. Key Raw Materials Table 190. Raw Materials Key Suppliers Table 191. Temperature Controlled Package for Pharmaceutical Distributors List Table 192. Temperature Controlled Package for Pharmaceutical Customers List Table 193. Research Programs/Design for This Report Table 194. Authors List of This Report Table 195. Secondary Sources Table 196. Primary Sources List of Figures Figure 1. Temperature Controlled Package for Pharmaceutical Product Image Figure 2. Global Temperature Controlled Package for Pharmaceutical Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Temperature Controlled Package for Pharmaceutical Sales Value (2021-2032) & (US$ Million) Figure 4. Global Temperature Controlled Package for Pharmaceutical Sales (2021-2032) & (K Units) Figure 5. Global Temperature Controlled Package for Pharmaceutical Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Temperature Controlled Package for Pharmaceutical Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Single Use Image Figure 10. Reusable Image Figure 11. Global Temperature Controlled Package for Pharmaceutical Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Temperature Controlled Package for Pharmaceutical Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Temperature Controlled Package for Pharmaceutical Sales Volume Share by Type (2021-2032) Figure 14. Global Temperature Controlled Package for Pharmaceutical Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Temperature Controlled Package for Pharmaceutical Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Temperature Controlled Package for Pharmaceutical Sales Value Share by Type (2021-2032) Figure 17. Temperature-Sensitive Pharmaceuticals Image Figure 18. Vaccines Image Figure 19. Others Image Figure 20. Global Temperature Controlled Package for Pharmaceutical Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Temperature Controlled Package for Pharmaceutical Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Temperature Controlled Package for Pharmaceutical Sales Volume Share by Application (2021-2032) Figure 23. Global Temperature Controlled Package for Pharmaceutical Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Temperature Controlled Package for Pharmaceutical Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Temperature Controlled Package for Pharmaceutical Sales Value Share by Application (2021-2032) Figure 26. Global Temperature Controlled Package for Pharmaceutical Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Temperature Controlled Package for Pharmaceutical Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Temperature Controlled Package for Pharmaceutical Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Temperature Controlled Package for Pharmaceutical Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Temperature Controlled Package for Pharmaceutical Sales Value (2021-2032) & (US$ Million) Figure 31. North America Temperature Controlled Package for Pharmaceutical Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Temperature Controlled Package for Pharmaceutical Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Temperature Controlled Package for Pharmaceutical Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Temperature Controlled Package for Pharmaceutical Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Temperature Controlled Package for Pharmaceutical Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Temperature Controlled Package for Pharmaceutical Sales Value (2021-2032) & (US$ Million) Figure 37. South America Temperature Controlled Package for Pharmaceutical Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Temperature Controlled Package for Pharmaceutical Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Temperature Controlled Package for Pharmaceutical Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Temperature Controlled Package for Pharmaceutical Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Temperature Controlled Package for Pharmaceutical Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interv

Scope & coverage.

Types
  • Single Use
  • Reusable
Applications
  • Temperature-Sensitive Pharmaceuticals
  • Vaccines
  • Others
Companies covered
  • Sonoco Products Company
  • Envirotainer
  • Pelican Biothermal
  • Cryopak
  • DS Smith Pharma
  • Cold Chain Technologies
  • Intelsius
  • CSafe
  • Softbox Systems
  • World Courier
  • Skycell
  • Va-Q-tec AG
  • Sofrigam SA Ltd.
  • American Aerogel Corporation
  • EcoCool GmbH
  • Aeris Group
  • Dokasch
  • HAZGO
  • Beijing Roloo Technology
  • Insulated Products Corporation
  • Inmark Packaging
  • Guangzhou CCTS
  • Exeltainer SL
  • Cool Pac
  • Cryo Store

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Temperature Controlled Package for Pharmaceutical Sales Value (2021-2032)
  4. 1.2.2 Global Temperature Controlled Package for Pharmaceutical Sales Volume (2021-2032)
  5. 1.2.3 Global Temperature Controlled Package for Pharmaceutical Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Temperature Controlled Package for Pharmaceutical Market Dynamics
  1. 2.1 Temperature Controlled Package for Pharmaceutical Industry Trends
  2. 2.2 Temperature Controlled Package for Pharmaceutical Industry Drivers
  3. 2.3 Temperature Controlled Package for Pharmaceutical Industry Opportunities and Challenges
  4. 2.4 Temperature Controlled Package for Pharmaceutical Industry Restraints
3 Temperature Controlled Package for Pharmaceutical Market by Company
  1. 3.1 Global Temperature Controlled Package for Pharmaceutical Company Revenue Ranking in 2025
  2. 3.2 Global Temperature Controlled Package for Pharmaceutical Revenue by Company (2021-2026)
  3. 3.3 Global Temperature Controlled Package for Pharmaceutical Sales Volume by Company (2021-2026)
  4. 3.4 Global Temperature Controlled Package for Pharmaceutical Average Price by Company (2021-2026)
  5. 3.5 Global Temperature Controlled Package for Pharmaceutical Company Ranking (2024-2026)
  6. 3.6 Global Temperature Controlled Package for Pharmaceutical Company Manufacturing Base and Headquarters
  7. 3.7 Global Temperature Controlled Package for Pharmaceutical Company Product Type and Application
  8. 3.8 Global Temperature Controlled Package for Pharmaceutical Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Temperature Controlled Package for Pharmaceutical Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Temperature Controlled Package for Pharmaceutical Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Temperature Controlled Package for Pharmaceutical Market by Type
  1. 4.1 Temperature Controlled Package for Pharmaceutical Type Introduction
  2. 4.1.1 Single Use
  3. 4.1.2 Reusable
  4. 4.2 Global Temperature Controlled Package for Pharmaceutical Sales Volume by Type
  5. 4.2.1 Global Temperature Controlled Package for Pharmaceutical Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Temperature Controlled Package for Pharmaceutical Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Temperature Controlled Package for Pharmaceutical Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Temperature Controlled Package for Pharmaceutical Sales Value by Type
  9. 4.3.1 Global Temperature Controlled Package for Pharmaceutical Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Temperature Controlled Package for Pharmaceutical Sales Value by Type (2021-2032)
  11. 4.3.3 Global Temperature Controlled Package for Pharmaceutical Sales Value Share by Type (2021-2032)
5 Temperature Controlled Package for Pharmaceutical Market by Application
  1. 5.1 Temperature Controlled Package for Pharmaceutical Application Introduction
  2. 5.1.1 Temperature-Sensitive Pharmaceuticals
  3. 5.1.2 Vaccines
  4. 5.1.3 Others
  5. 5.2 Global Temperature Controlled Package for Pharmaceutical Sales Volume by Application
  6. 5.2.1 Global Temperature Controlled Package for Pharmaceutical Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Temperature Controlled Package for Pharmaceutical Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Temperature Controlled Package for Pharmaceutical Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Temperature Controlled Package for Pharmaceutical Sales Value by Application
  10. 5.3.1 Global Temperature Controlled Package for Pharmaceutical Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Temperature Controlled Package for Pharmaceutical Sales Value by Application (2021-2032)
  12. 5.3.3 Global Temperature Controlled Package for Pharmaceutical Sales Value Share by Application (2021-2032)
6 Temperature Controlled Package for Pharmaceutical Regional Sales and Value Analysis
  1. 6.1 Global Temperature Controlled Package for Pharmaceutical Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Temperature Controlled Package for Pharmaceutical Sales by Region (2021-2032)
  3. 6.2.1 Global Temperature Controlled Package for Pharmaceutical Sales by Region: 2021-2026
  4. 6.2.2 Global Temperature Controlled Package for Pharmaceutical Sales by Region (2027-2032)
  5. 6.3 Global Temperature Controlled Package for Pharmaceutical Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Temperature Controlled Package for Pharmaceutical Sales Value by Region (2021-2032)
  7. 6.4.1 Global Temperature Controlled Package for Pharmaceutical Sales Value by Region: 2021-2026
  8. 6.4.2 Global Temperature Controlled Package for Pharmaceutical Sales Value by Region (2027-2032)
  9. 6.5 Global Temperature Controlled Package for Pharmaceutical Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Temperature Controlled Package for Pharmaceutical Sales Value (2021-2032)
  12. 6.6.2 North America Temperature Controlled Package for Pharmaceutical Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Temperature Controlled Package for Pharmaceutical Sales Value (2021-2032)
  15. 6.7.2 Europe Temperature Controlled Package for Pharmaceutical Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Temperature Controlled Package for Pharmaceutical Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Temperature Controlled Package for Pharmaceutical Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Temperature Controlled Package for Pharmaceutical Sales Value (2021-2032)
  21. 6.9.2 South America Temperature Controlled Package for Pharmaceutical Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Temperature Controlled Package for Pharmaceutical Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Temperature Controlled Package for Pharmaceutical Sales Value Share by Country, 2025 VS 2032
7 Temperature Controlled Package for Pharmaceutical Country-level Sales and Value Analysis
  1. 7.1 Global Temperature Controlled Package for Pharmaceutical Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Temperature Controlled Package for Pharmaceutical Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Temperature Controlled Package for Pharmaceutical Sales by Country (2021-2032)
  4. 7.3.1 Global Temperature Controlled Package for Pharmaceutical Sales by Country (2021-2026)
  5. 7.3.2 Global Temperature Controlled Package for Pharmaceutical Sales by Country (2027-2032)
  6. 7.4 Global Temperature Controlled Package for Pharmaceutical Sales Value by Country (2021-2032)
  7. 7.4.1 Global Temperature Controlled Package for Pharmaceutical Sales Value by Country (2021-2026)
  8. 7.4.2 Global Temperature Controlled Package for Pharmaceutical Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Temperature Controlled Package for Pharmaceutical Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Temperature Controlled Package for Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Temperature Controlled Package for Pharmaceutical Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sonoco Products Company
  2. 8.1.1 Sonoco Products Company Company Information
  3. 8.1.2 Sonoco Products Company Business Overview
  4. 8.1.3 Sonoco Products Company Temperature Controlled Package for Pharmaceutical Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sonoco Products Company Temperature Controlled Package for Pharmaceutical Product Portfolio
  6. 8.1.5 Sonoco Products Company Recent Developments
  7. 8.2 Envirotainer
  8. 8.2.1 Envirotainer Company Information
  9. 8.2.2 Envirotainer Business Overview
  10. 8.2.3 Envirotainer Temperature Controlled Package for Pharmaceutical Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Envirotainer Temperature Controlled Package for Pharmaceutical Product Portfolio
  12. 8.2.5 Envirotainer Recent Developments
  13. 8.3 Pelican Biothermal
  14. 8.3.1 Pelican Biothermal Company Information
  15. 8.3.2 Pelican Biothermal Business Overview
  16. 8.3.3 Pelican Biothermal Temperature Controlled Package for Pharmaceutical Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Pelican Biothermal Temperature Controlled Package for Pharmaceutical Product Portfolio
  18. 8.3.5 Pelican Biothermal Recent Developments
  19. 8.4 Cryopak
  20. 8.4.1 Cryopak Company Information
  21. 8.4.2 Cryopak Business Overview
  22. 8.4.3 Cryopak Temperature Controlled Package for Pharmaceutical Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Cryopak Temperature Controlled Package for Pharmaceutical Product Portfolio
  24. 8.4.5 Cryopak Recent Developments
  25. 8.5 DS Smith Pharma
  26. 8.5.1 DS Smith Pharma Company Information
  27. 8.5.2 DS Smith Pharma Business Overview
  28. 8.5.3 DS Smith Pharma Temperature Controlled Package for Pharmaceutical Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 DS Smith Pharma Temperature Controlled Package for Pharmaceutical Product Portfolio
  30. 8.5.5 DS Smith Pharma Recent Developments
  31. 8.6 Cold Chain Technologies
  32. 8.6.1 Cold Chain Technologies Company Information
  33. 8.6.2 Cold Chain Technologies Business Overview
  34. 8.6.3 Cold Chain Technologies Temperature Controlled Package for Pharmaceutical Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Cold Chain Technologies Temperature Controlled Package for Pharmaceutical Product Portfolio
  36. 8.6.5 Cold Chain Technologies Recent Developments
  37. 8.7 Intelsius
  38. 8.7.1 Intelsius Company Information
  39. 8.7.2 Intelsius Business Overview
  40. 8.7.3 Intelsius Temperature Controlled Package for Pharmaceutical Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Intelsius Temperature Controlled Package for Pharmaceutical Product Portfolio
  42. 8.7.5 Intelsius Recent Developments
  43. 8.8 CSafe
  44. 8.8.1 CSafe Company Information
  45. 8.8.2 CSafe Business Overview
  46. 8.8.3 CSafe Temperature Controlled Package for Pharmaceutical Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 CSafe Temperature Controlled Package for Pharmaceutical Product Portfolio
  48. 8.8.5 CSafe Recent Developments
  49. 8.9 Softbox Systems
  50. 8.9.1 Softbox Systems Company Information
  51. 8.9.2 Softbox Systems Business Overview
  52. 8.9.3 Softbox Systems Temperature Controlled Package for Pharmaceutical Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Softbox Systems Temperature Controlled Package for Pharmaceutical Product Portfolio
  54. 8.9.5 Softbox Systems Recent Developments
  55. 8.10 World Courier
  56. 8.10.1 World Courier Company Information
  57. 8.10.2 World Courier Business Overview
  58. 8.10.3 World Courier Temperature Controlled Package for Pharmaceutical Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 World Courier Temperature Controlled Package for Pharmaceutical Product Portfolio
  60. 8.10.5 World Courier Recent Developments
  61. 8.11 Skycell
  62. 8.11.1 Skycell Company Information
  63. 8.11.2 Skycell Business Overview
  64. 8.11.3 Skycell Temperature Controlled Package for Pharmaceutical Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Skycell Temperature Controlled Package for Pharmaceutical Product Portfolio
  66. 8.11.5 Skycell Recent Developments
  67. 8.12 Va-Q-tec AG
  68. 8.12.1 Va-Q-tec AG Company Information
  69. 8.12.2 Va-Q-tec AG Business Overview
  70. 8.12.3 Va-Q-tec AG Temperature Controlled Package for Pharmaceutical Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Va-Q-tec AG Temperature Controlled Package for Pharmaceutical Product Portfolio
  72. 8.12.5 Va-Q-tec AG Recent Developments
  73. 8.13 Sofrigam SA Ltd.
  74. 8.13.1 Sofrigam SA Ltd. Company Information
  75. 8.13.2 Sofrigam SA Ltd. Business Overview
  76. 8.13.3 Sofrigam SA Ltd. Temperature Controlled Package for Pharmaceutical Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Sofrigam SA Ltd. Temperature Controlled Package for Pharmaceutical Product Portfolio
  78. 8.13.5 Sofrigam SA Ltd. Recent Developments
  79. 8.14 American Aerogel Corporation
  80. 8.14.1 American Aerogel Corporation Company Information
  81. 8.14.2 American Aerogel Corporation Business Overview
  82. 8.14.3 American Aerogel Corporation Temperature Controlled Package for Pharmaceutical Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 American Aerogel Corporation Temperature Controlled Package for Pharmaceutical Product Portfolio
  84. 8.14.5 American Aerogel Corporation Recent Developments
  85. 8.15 EcoCool GmbH
  86. 8.15.1 EcoCool GmbH Company Information
  87. 8.15.2 EcoCool GmbH Business Overview
  88. 8.15.3 EcoCool GmbH Temperature Controlled Package for Pharmaceutical Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 EcoCool GmbH Temperature Controlled Package for Pharmaceutical Product Portfolio
  90. 8.15.5 EcoCool GmbH Recent Developments
  91. 8.16 Aeris Group
  92. 8.16.1 Aeris Group Company Information
  93. 8.16.2 Aeris Group Business Overview
  94. 8.16.3 Aeris Group Temperature Controlled Package for Pharmaceutical Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Aeris Group Temperature Controlled Package for Pharmaceutical Product Portfolio
  96. 8.16.5 Aeris Group Recent Developments
  97. 8.17 Dokasch
  98. 8.17.1 Dokasch Company Information
  99. 8.17.2 Dokasch Business Overview
  100. 8.17.3 Dokasch Temperature Controlled Package for Pharmaceutical Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Dokasch Temperature Controlled Package for Pharmaceutical Product Portfolio
  102. 8.17.5 Dokasch Recent Developments
  103. 8.18 HAZGO
  104. 8.18.1 HAZGO Company Information
  105. 8.18.2 HAZGO Business Overview
  106. 8.18.3 HAZGO Temperature Controlled Package for Pharmaceutical Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 HAZGO Temperature Controlled Package for Pharmaceutical Product Portfolio
  108. 8.18.5 HAZGO Recent Developments
  109. 8.19 Beijing Roloo Technology
  110. 8.19.1 Beijing Roloo Technology Company Information
  111. 8.19.2 Beijing Roloo Technology Business Overview
  112. 8.19.3 Beijing Roloo Technology Temperature Controlled Package for Pharmaceutical Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Beijing Roloo Technology Temperature Controlled Package for Pharmaceutical Product Portfolio
  114. 8.19.5 Beijing Roloo Technology Recent Developments
  115. 8.20 Insulated Products Corporation
  116. 8.20.1 Insulated Products Corporation Company Information
  117. 8.20.2 Insulated Products Corporation Business Overview
  118. 8.20.3 Insulated Products Corporation Temperature Controlled Package for Pharmaceutical Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Insulated Products Corporation Temperature Controlled Package for Pharmaceutical Product Portfolio
  120. 8.20.5 Insulated Products Corporation Recent Developments
  121. 8.21 Inmark Packaging
  122. 8.21.1 Inmark Packaging Company Information
  123. 8.21.2 Inmark Packaging Business Overview
  124. 8.21.3 Inmark Packaging Temperature Controlled Package for Pharmaceutical Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 Inmark Packaging Temperature Controlled Package for Pharmaceutical Product Portfolio
  126. 8.21.5 Inmark Packaging Recent Developments
  127. 8.22 Guangzhou CCTS
  128. 8.22.1 Guangzhou CCTS Company Information
  129. 8.22.2 Guangzhou CCTS Business Overview
  130. 8.22.3 Guangzhou CCTS Temperature Controlled Package for Pharmaceutical Sales, Value and Gross Margin (2021-2026)
  131. 8.22.4 Guangzhou CCTS Temperature Controlled Package for Pharmaceutical Product Portfolio
  132. 8.22.5 Guangzhou CCTS Recent Developments
  133. 8.23 Exeltainer SL
  134. 8.23.1 Exeltainer SL Company Information
  135. 8.23.2 Exeltainer SL Business Overview
  136. 8.23.3 Exeltainer SL Temperature Controlled Package for Pharmaceutical Sales, Value and Gross Margin (2021-2026)
  137. 8.23.4 Exeltainer SL Temperature Controlled Package for Pharmaceutical Product Portfolio
  138. 8.23.5 Exeltainer SL Recent Developments
  139. 8.24 Cool Pac
  140. 8.24.1 Cool Pac Company Information
  141. 8.24.2 Cool Pac Business Overview
  142. 8.24.3 Cool Pac Temperature Controlled Package for Pharmaceutical Sales, Value and Gross Margin (2021-2026)
  143. 8.24.4 Cool Pac Temperature Controlled Package for Pharmaceutical Product Portfolio
  144. 8.24.5 Cool Pac Recent Developments
  145. 8.25 Cryo Store
  146. 8.25.1 Cryo Store Company Information
  147. 8.25.2 Cryo Store Business Overview
  148. 8.25.3 Cryo Store Temperature Controlled Package for Pharmaceutical Sales, Value and Gross Margin (2021-2026)
  149. 8.25.4 Cryo Store Temperature Controlled Package for Pharmaceutical Product Portfolio
  150. 8.25.5 Cryo Store Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Temperature Controlled Package for Pharmaceutical Value Chain Analysis
  2. 9.1.1 Temperature Controlled Package for Pharmaceutical Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Temperature Controlled Package for Pharmaceutical Sales Mode & Process
  6. 9.2 Temperature Controlled Package for Pharmaceutical Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Temperature Controlled Package for Pharmaceutical Distributors
  9. 9.2.3 Temperature Controlled Package for Pharmaceutical Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst